What is the treatment for subconjunctival hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Subconjunctival Hemorrhage

Subconjunctival hemorrhage requires no specific treatment beyond observation and reassurance, as it typically resolves spontaneously within 1-2 weeks without intervention. 1

Understanding Subconjunctival Hemorrhage

  • Subconjunctival hemorrhage is a benign condition characterized by bleeding under the conjunctiva, causing a bright red appearance on the white of the eye 2
  • It is a common cause of acute ocular redness that usually resolves without treatment 2
  • The condition may appear alarming to patients but rarely affects vision or causes discomfort 3

Management Approach

Primary Treatment

  • Observation is the standard treatment as most cases resolve spontaneously within 1-2 weeks 1, 3
  • No specific medication or intervention is typically required 3
  • Patient reassurance about the benign nature of the condition is important 3

Supportive Measures (if needed)

  • Artificial tears or lubricants may provide comfort if mild irritation is present 1
  • Cold compresses may help reduce any minor discomfort in the acute phase 3
  • Avoiding eye rubbing to prevent further bleeding 2

Special Considerations

Recurrent Subconjunctival Hemorrhages

  • Recurrent episodes warrant further evaluation for underlying causes 2
  • Consider assessment for:
    • Systemic hypertension 2
    • Bleeding disorders 2, 4
    • Medication effects (anticoagulants, aspirin, NSAIDs) 5, 2
    • Conjunctivochalasis (redundant conjunctival tissue) 6

Conjunctivochalasis and Subconjunctival Hemorrhage

  • Moderate to severe conjunctivochalasis is associated with recurrent subconjunctival hemorrhages 6
  • Surgical correction of conjunctivochalasis may be considered in patients with frequent recurrences (>80% success rate in preventing further episodes) 6

When to Refer

  • Persistent hemorrhage beyond 2-3 weeks 2
  • Recurrent episodes (three or more) 6
  • Associated symptoms such as pain, vision changes, or discharge 3
  • Suspected underlying systemic disease 2

Risk Factors to Assess

  • Trauma and contact lens use (more common in younger patients) 2
  • Systemic vascular diseases including hypertension, diabetes, and arteriosclerosis (more common in elderly) 2
  • Activities requiring visual concentration (watching screens, reading, driving) 6
  • Use of blood thinners or anticoagulants 5

Clinical Pearls

  • Despite its dramatic appearance, subconjunctival hemorrhage is typically harmless and self-limiting 3
  • The condition does not usually require laboratory testing unless recurrent or associated with other bleeding manifestations 4
  • Routine hemostatic screening is not indicated for isolated subconjunctival hemorrhage 4
  • Patient education about the benign nature of the condition is essential to reduce anxiety 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Subconjunctival hemorrhage: risk factors and potential indicators.

Clinical ophthalmology (Auckland, N.Z.), 2013

Research

Subconjunctival hemorrhage: overview and management.

Journal of the American Optometric Association, 1986

Research

Subconjunctival and external hemorrhage secondary to oral anticoagulation.

Journal of the American Optometric Association, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.